THE ROLE OF PROCALCITONIN AS A MARKER IN CHRONIC RHEUMATIC HEART DISEASE
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Chronic rheumatic heart disease (CRHD) remains one of the leading causes of acquired heart defects in children and adolescents in developing countries. Procalcitonin (PCT), a peptide precursor of calcitonin, is a sensitive marker of systemic inflammatory response and may reflect the activity of rheumatic inflammation and secondary bacterial infection. Determining serum procalcitonin levels may improve the early diagnosis, prognosis, and management of CRHD during exacerbations.
Fields of Study & Subjects
Streptococcal Infections and Treatments
Sepsis Diagnosis and Treatment
Biomarkers in Disease Mechanisms
Publication details
- Journal / source
- International Multidisciplinary Journal for Research & Development
- Publication date
- 27 March 2026
- Language
- EN